CLBT — Cellebrite DI Ltd.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-11-06.
Performance
Technicals
Others in Technology
Measured signals that fired on CLBT
| date | signal | measured base rate |
|---|---|---|
| 2026-08-13 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-08-13 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
| 2026-06-29 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-09 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-06-01 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-04-16 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-12 | Hogan Thomas E. Chief Executive Officer | Open-market sale | 139.7K | 15.39 | 2.1M |
| 2026-08-12 | Jewell Marcus Global Chief Revenue Officer | Open-market sale | 411 | 16.07 | 6.6K |
| 2026-08-12 | GEE DAVID NICHOLAS Chief Marketing Officer | Open-market sale | 230 | 16.07 | 3.7K |
| 2026-08-11 | Hogan Thomas E. Chief Executive Officer | Grant or award | 339.5K | 0.00 | 0 |
| 2026-07-08 | Barter David Chief Financial Officer | Open-market sale | 41.7K | 16.38 | 683.4K |
| 2026-07-02 | Hogan Thomas E. Chief Executive Officer | Open-market sale | 103.2K | 15.76 | 1.6M |
| 2026-05-21 | GEE DAVID NICHOLAS Chief Marketing Officer | Open-market sale 10b5-1 plan | 3.4K | 13.15 | 45.1K |
| 2026-05-21 | GEE DAVID NICHOLAS Chief Marketing Officer | Open-market sale 10b5-1 plan | 2.2K | 13.10 | 29.4K |
| 2026-05-18 | Jewell Marcus Global Chief Revenue Officer | Open-market sale | 12.7K | 12.77 | 161.7K |
| 2026-05-12 | Jewell Marcus Global Chief Revenue Officer | Open-market sale | 383 | 13.01 | 5.0K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| True Wind Capital Management, L.P. | 191.0M | 13.9M |
| Voss Capital, LP | 133.3M | 9.7M |
| FMR LLC | 117.0M | 8.5M |
| Pertento Partners LLP | 91.8M | 6.7M |
| Phoenix Financial Ltd. | 57.6M | 4.2M |
| Nine Ten Capital Management LLC | 47.5M | 3.4M |
| BlackRock, Inc. | 46.0M | 3.3M |
| RENAISSANCE TECHNOLOGIES LLC | 39.4M | 2.9M |
| BROWN CAPITAL MANAGEMENT LLC | 37.2M | 2.7M |
| Capital International Investors | 31.4M | 2.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 144 | 2026-08-19 | — | on EDGAR ↗ |
| 144 | 2026-08-19 | — | on EDGAR ↗ |
| SCHEDULE 13G | 2026-08-18 | — | on EDGAR ↗ |
| 6-K | 2026-08-18 | 2026-08-18 | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-11 | on EDGAR ↗ |
| 6-K | 2026-08-13 | 2026-08-13 | on EDGAR ↗ |
| 6-K | 2026-08-13 | 2026-06-30 | on EDGAR ↗ |
| 4 | 2026-08-13 | 2026-08-12 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Cellebrite DI Ltd. (CLBT) Securities Investigation Notice - Levi & Korsinsky · 2026-08-20
- Cellebrite Genesis for Enterprise ist ab sofort allgemein verfügbar und wird in weiteren internationalen Märkten angeboten · 2026-08-19
- Désormais accessible à toutes les entreprises, Cellebrite Genesis for Enterprise étend sa disponibilité régionale à davantage de marchés mondiaux · 2026-08-19
- Cellebrite DI Ltd. (CLBT) filed form 144 · 2026-08-19 · SEC EDGAR
- Cellebrite DI Ltd. (CLBT) filed form 144 · 2026-08-19 · SEC EDGAR
- Cellebrite DI Ltd. (CLBT) filed form SCHEDULE 13G · 2026-08-18 · SEC EDGAR
Ask the AI about CLBT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →